Alessandra Nardin

Alessandra Nardin has a diverse work experience spanning over several companies and roles. Alessandra started their career as a Research Fellow at the Istituto Zooprofilattico della Lombardia e dell'Emilia in 1994. Alessandra then worked as a Research Associate at the University of Virginia from 1996 to 1999.

In 1999, Alessandra joined IDM Pharma as a Senior Scientist. Alessandra later took on the role of Manager Research Program, where they supervised preclinical studies on cancer immunotherapy strategies. Their responsibilities included characterization and optimization of dendritic cell maturation and macrophage activation.

In 2006, Alessandra joined the Singapore Immunology Network, A*STAR as a Senior Scientist. Alessandra later became the Principal Investigator Technologist, leading the Translational Immunology Group and managing collaborations with industry. Alessandra also facilitated clinical research studies and was involved in intellectual property valorization.

Alessandra's most recent position is with ImmunoScape, where they co-founded the company and served as the COO from 2017 to 2022. Alessandra is currently the Vice President of Strategy, a role they assumed in January 2023.

Throughout their career, Alessandra has demonstrated expertise in translational immunology, cancer immunotherapy strategies, and project management.

Alessandra Nardin obtained their DVM degree in Veterinary Medicine from the Università degli Studi di Parma, where they studied from 1988 until 1994.